Free Trial

Sintx Technologies (SINT) Competitors

$5.15
-0.72 (-12.27%)
(As of 06/7/2024 ET)

SINT vs. PETV, PAVM, BTCY, VVOS, NURO, INBS, VERO, VAPO, TMDIF, and STSS

Should you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include PetVivo (PETV), PAVmed (PAVM), Biotricity (BTCY), Vivos Therapeutics (VVOS), NeuroMetrix (NURO), Intelligent Bio Solutions (INBS), Venus Concept (VERO), Vapotherm (VAPO), Titan Medical (TMDIF), and Sharps Technology (STSS). These companies are all part of the "surgical & medical instruments" industry.

Sintx Technologies vs.

PetVivo (NASDAQ:PETV) and Sintx Technologies (NASDAQ:SINT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, community ranking, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

Sintx Technologies received 36 more outperform votes than PetVivo when rated by MarketBeat users.

CompanyUnderperformOutperform
PetVivoN/AN/A
Sintx TechnologiesOutperform Votes
36
61.02%
Underperform Votes
23
38.98%

Sintx Technologies has higher revenue and earnings than PetVivo. PetVivo is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PetVivo$920K12.40-$8.72M-$0.86-0.79
Sintx Technologies$1.30M2.44-$8.26M-$358.00-0.01

Sintx Technologies has a net margin of -318.99% compared to Sintx Technologies' net margin of -1,016.64%. PetVivo's return on equity of -81.96% beat Sintx Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
PetVivo-1,016.64% -1,319.59% -299.92%
Sintx Technologies -318.99%-81.96%-52.43%

24.6% of PetVivo shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 20.1% of PetVivo shares are owned by company insiders. Comparatively, 1.0% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

PetVivo has a beta of 2.24, indicating that its stock price is 124% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500.

In the previous week, PetVivo and PetVivo both had 1 articles in the media. Sintx Technologies' average media sentiment score of 0.00 equaled PetVivo'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PetVivo
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Sintx Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Sintx Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Sintx Technologies beats PetVivo on 7 of the 12 factors compared between the two stocks.

Get Sintx Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SINT vs. The Competition

MetricSintx TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3.16M$3.93B$5.22B$8.17B
Dividend YieldN/A1.79%2.73%4.04%
P/E Ratio-0.019.10114.4714.45
Price / Sales2.4468.802,426.4168.78
Price / CashN/A48.3435.1231.03
Price / Book0.024.314.964.32
Net Income-$8.26M$4.50M$110.41M$216.21M
7 Day Performance-28.97%-1.00%-1.08%-1.44%
1 Month Performance-42.00%-0.39%-0.64%-0.60%
1 Year Performance-98.42%-18.40%2.85%3.53%

Sintx Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
0 of 5 stars
$0.68
-2.9%
N/A-66.5%$11.40M$920,000.00-0.7925News Coverage
PAVM
PAVmed
1.2684 of 5 stars
$1.16
+2.7%
$21.00
+1,710.3%
-83.2%$10.94M$2.45M-0.13107Gap Down
BTCY
Biotricity
0.0567 of 5 stars
$1.08
+1.9%
N/AN/A$10.17M$9.64M-0.7855News Coverage
Positive News
VVOS
Vivos Therapeutics
0 of 5 stars
$2.45
+6.5%
N/A-76.5%$7.91M$13.80M-0.22114
NURO
NeuroMetrix
0 of 5 stars
$3.82
+1.1%
N/A-52.3%$7.67M$5.90M-0.6126Analyst Forecast
INBS
Intelligent Bio Solutions
0 of 5 stars
$1.95
-6.7%
N/A-94.6%$6.08M$1.26M-0.0551Gap Down
VERO
Venus Concept
1.1289 of 5 stars
$0.93
+57.6%
N/A-58.7%$5.92M$76.35M-0.14304News Coverage
Gap Up
High Trading Volume
VAPO
Vapotherm
0 of 5 stars
$0.80
+6.7%
N/A-85.7%$4.98M$68.67M-0.09182Gap Up
TMDIF
Titan Medical
0 of 5 stars
$0.04
+31.4%
N/A-73.3%$4.77M$17.63M0.844Gap Down
STSS
Sharps Technology
0 of 5 stars
$0.28
-6.7%
N/A-70.9%$4.37MN/A0.0057News Coverage
Gap Down

Related Companies and Tools

This page (NASDAQ:SINT) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners